查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
吸入器和鼻腔噴霧仿製藥市場規模、份額和趨勢分析報告：按藥物類別、適應症、患者細分、最終用戶、分銷渠道、地區、細分市場預測，2022-2030
市場調查報告書
商品編碼
1122262

吸入器和鼻腔噴霧仿製藥市場規模、份額和趨勢分析報告：按藥物類別、適應症、患者細分、最終用戶、分銷渠道、地區、細分市場預測，2022-2030

Inhalation And Nasal Spray Generic Drugs Market Size, Share & Trends Analysis Report By Drug Class, By Indication, By Patient Demographics, By End-user, By Distribution Channel, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 160 Pages | 商品交期: 2-10個工作天內

價格

吸入器和鼻噴霧仿製藥市場增長和趨勢

根據 Grandview Research 的一份新報告，到 2030 年，全球仿製藥吸入器和鼻噴霧劑市場預計將達到 384 億美元。從 2022 年到 2030 年，市場預計將以 8.96% 的複合年增長率增長。新產品的推出、慢性呼吸道疾病的流行、對具有成本效益的藥品的需求不斷增加以及老年人口的增加是推動市場增長的主要因素。

在預測期內，對具有成本效益的藥物的需求不斷增長以及政府對使用仿製藥的支持預計將推動對用於吸入器和鼻噴霧劑的仿製藥的需求。例如，日本政府提倡使用廉價的仿製藥來調節總體藥品支出。這是通過在過去十年中實施鼓勵使用仿製藥的法規來實現的。

Teva Pharmaceuticals、Glenmark Specialty SA 和 Hikma Pharmaceuticals PLC 等領先製造商之間增加的併購、合作夥伴關係和合作也是增長的主要驅動力之一。例如，2022 年 1 月，Glenmark Pharmaceuticals Ltd. 的瑞士子公司 Glenmark Specialty SA 將與 Lotus International Pte. Ltd. 合作，在越南、香港和新加坡銷售 Lilatris 鼻噴霧劑。根據協議條款，Glenmark Specialty SA 將生產和供應 Lialtolis，由 Lotus International Pte 進行商業化。同樣，2020 年 2 月，Glenmark Specialty 與 Higuma Pharmaceuticals PLC 就 ryaltoricin 在美國的商業化簽訂了許可協議。

製藥公司在呼吸藥物發現和吸入器和鼻噴霧劑的仿製藥批准方面的廣泛研究預計將推動增長。例如，2021 年 3 月，Cipla Inc. 獲得了美國 FDA 對舒馬曲坦鼻噴霧劑的 ANDA 批准，舒馬曲坦鼻噴霧劑是 Imitrex 鼻噴霧劑的通用版本，用於治療偏頭痛。2020 年 5 月，隨著 Migranal 仿製藥 Dihydroergotamine Mesilate Nasal Drop 的 ANDA 批准，FDA 還授予了競爭性仿製藥名稱。

吸入器和鼻腔噴霧仿製藥市場報告亮點

按藥物類別劃分，由於 COPD 和哮喘的高患病率，支氣管擴張劑在 2021 年佔據市場主導地位

由於仿製藥的推出以及中低收入國家慢性阻塞性肺病（COPD）患病率的增加，預計慢性阻塞性肺病（COPD）適應症部分在預測期內增長最快。

根據患者人口統計，由於接觸環境過敏原（如污染、吸煙和花粉）的增加，預計兒科患者在預測期內增長最快

慢性病患病率上升和患有慢性呼吸系統疾病的老年人口不斷增加，推動家庭護理最終用戶細分市場在 2021 年佔據主導地位

由於處方成本低、互聯網普及率提高和訪問便利等消費者需求，預計在線藥房分銷渠道在預測期內增長最快。

2021年，北美主導市場。這是由於領先公司在該地區開發和推出仿製藥的戰略舉措和合作夥伴關係。

目錄

第一章 調查方法和範圍

  • 市場細分
  • 調查方法
  • 信息採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 次要信息
    • 初步調查
    • 第一次調查的內容
    • 主要信息列表
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 型號詳情
    • 商品流向分析
      • 方法一：商品流動方法
      • 方法 2：使用自下而上的方法進行國別市場估算
  • 全球市場：複合年增長率計算
  • 調查假設
  • 二級信息列表
  • 縮略語表
  • 目的

第二章執行摘要

  • 市場概況

第三章市場變量、趨勢和範圍

  • 市場系列展望
    • 母公司的市場前景
  • 監管框架
  • 繪製滲透率和增長前景
  • 管道分析
  • 市場動態
    • 市場驅動力分析
    • 市場約束分析
  • PESTEL 分析

4 2018-2030 年全球吸入器和鼻腔噴霧仿製藥市場細分分析，按藥物類別（百萬美元）

  • 全球吸入和鼻腔噴霧仿製藥市場：藥物類別變化分析
  • 支氣管擴張劑
  • 配合劑
  • 皮質類固醇
  • 減充血噴霧
  • 抗組胺藥
  • 其他

5 全球吸入器和鼻腔噴霧仿製藥市場細分分析，按適應症，2018-2030 年（百萬美元）

  • 全球吸入和鼻腔噴霧仿製藥市場：適應症變化分析
  • 哮喘
  • 慢性阻塞性肺病（COPD）
  • 過敏性鼻炎
  • 其他

第 6 章全球吸入器和鼻腔噴霧仿製藥市場細分分析，患者人口統計，2018-2030 年（百萬美元）

  • 全球吸入器和鼻腔噴霧仿製藥市場：患者人口統計變化分析
  • 成年患者
  • 兒科病人
  • 老年患者

第 7 章全球吸入器和鼻腔噴霧仿製藥市場細分分析，按最終用戶，2018-2030 年（百萬美元）

  • 全球吸入和鼻腔噴霧仿製藥市場：最終用戶變化分析
  • 醫院
  • 癌症研究所
  • 其他

8 2018-2030 年按分銷渠道分列的全球吸入器和鼻腔噴霧仿製藥市場細分分析（百萬美元）

  • 全球吸入器和鼻腔噴霧仿製藥市場：分銷渠道動態分析
  • 零售藥店
  • 醫院藥房
  • 網上藥店

9. 吸入器和鼻腔噴霧仿製藥市場：細分分析，按地區，2018-2030 年（百萬美元）

  • 吸入器和鼻噴霧仿製藥市場：區域差異分析
    • 北美
      • 美國
      • 加拿大
    • 歐洲
      • 英國
      • 德國
      • 法國
      • 西班牙
      • 意大利
      • 俄羅斯
    • 亞太地區
      • 日本
      • 中國
      • 印度
      • 澳大利亞
      • 韓國
      • 新加坡
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
    • 中東和非洲
      • 南非
      • 沙特阿拉伯
      • 阿拉伯聯合酋長國

10 全球吸入器和鼻腔噴霧仿製藥市場：競爭分析

  • 主要市場參與者的最新發展和影響分析
    • 重大交易和戰略聯盟分析
      • 新產品發布
      • 併購
      • 夥伴關係和合同
  • 公司分類
    • 創新者
    • 市場領導者
    • 新興玩家
    • 熱圖分析
  • 公司市場分析
  • 供應商情況
    • 主要經銷商及渠道合作夥伴名單
    • 潛在最終用戶列表
    • 2021 年主要參與者的市場份額分析
  • 2021年公司市場份額
    • 競爭儀錶盤分析
  • 民營企業
    • 主要初創企業名單
    • 區域網絡圖
  • 公司簡介
    • Teva Pharmaceuticals
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Viatris Inc.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Akorn, Inc.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Cipla Inc.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Sandoz（Novartis AG）
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Apotex Inc.
      • 公司簡介
      • 產品基準
      • 戰略舉措
    • Hikma Pharmaceuticals PLC
      • 公司簡介
      • 財務績效
      • 產品基準
    • Sun Pharma
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Beximco Pharmaceuticals Limited
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Nephron Pharma
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
Product Code: GVR-4-68039-965-9

Inhalation And Nasal Spray Generic Drugs Market Growth & Trends:

The global inhalation and nasal spray generic drugs market size is expected to reach USD 38.40 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.96% from 2022 to 2030. New product launches, mounting prevalence of chronic respiratory diseases, growing demand for cost-effective medicines, and rising geriatric population are some of the major factors boosting the market growth.

Rising demand for cost-effective medicines and government support for the use of generics is expected to drive the demand for inhalation and nasal spray generic drugs over the forecast period. For instance, the Government of Japan has been promoting the usage of inexpensive generic drugs in order to regulate the overall pharmaceutical expenditure. This was accomplished through the execution of regulations to encourage the use of generic drugs in the past decade.

Rising number of M&A, partnerships, and collaborations among leading manufacturers including Teva Pharmaceuticals, Glenmark Specialty S.A., and Hikma Pharmaceuticals PLC is another major factor propelling the growth. For instance, in January 2022, Glenmark Specialty S.A., a Swiss subsidiary of Glenmark Pharmaceuticals Ltd., partnered with Lotus International Pte. Ltd. for marketing Ryaltris nasal spray in Vietnam, Hong Kong, and Singapore. Under this agreement, Glenmark Specialty S.A. will manufacture and supply Ryaltris, and Lotus International Pte. Ltd. will commercialize the product. Similarly, in February 2020, Glenmark Specialty signed a licensing agreement with Hikma Pharmaceuticals PLC to commercialize Ryaltrisin in the U.S.

Extensive research in the respiratory drug discovery and generic product approvals of inhalation and nasal drugs by pharmaceutical companies are projected to fuel growth. For instance, in March 2021, Cipla Inc. received ANDA approval from the U.S. FDA for Sumatriptan Nasal Spray, a generic equivalent of Imitrex Nasal Spray indicated for migraine treatment. In addition, in May 2020, the company received Competitive Generic Therapy designation from FDA along with ANDA approval for Dihydroergotamine Mesylate Nasal Spray, a generic version of Migranal.

Inhalation And Nasal Spray Generic Drugs Market Report Highlights:

  • By drug class, bronchodilators dominated the market in 2021 owing to the high prevalence of COPD and asthma in the population
  • The chronic obstructive pulmonary disease (COPD) indication segment is expected to witness the fastest growth over the forecast period due to the launch of generic products and increased prevalence of COPD in low- and middle-income countries
  • Based on patient demographics, the pediatric patients segment is expected to witness the fastest growth over the forecast period due to an increase in pollution, smoking, and exposure to environmental allergens such as pollens
  • The homecare end-user segment dominated the market in 2021 owing to a rise in the prevalence of chronic diseases and rising geriatric population suffering from chronic respiratory diseases
  • The online pharmacies distribution channel segment is expected to witness the fastest growth over the forecast period due to consumer needs for low prescription costs, increased internet penetration, and ease of access
  • North America dominated the market in 2021 due to strategic initiatives and collaborations among key players for the development and launch of generic products in this region

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market segmentation
    • 1.1.1 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased database
    • 1.3.2 GVR'S internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
    • 1.3.6 List of primary sources
  • 1.4 Information or data analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity flow analysis
      • 1.6.1.1 Approach 1: Commodity Flow Approach
      • 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
  • 1.7 Global Market: CAGR Calculation
  • 1.8 Research Assumptions
  • 1.9 List of Secondary Sources
  • 1.10 List of Abbreviations
  • 1.11 Objectives
    • 1.11.1 Objective 1
    • 1.11.2 Objective 2
    • 1.11.3 Objective 3
    • 1.11.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Summary

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
  • 3.2 Regulatory framework
  • 3.3 Penetration and Growth Prospect Mapping
  • 3.4 Pipeline Analysis
  • 3.5 Market Dynamics
    • 3.5.1 Market driver analysis
    • 3.5.2 Market restraint analysis
  • 3.6 PESTEL Analysis

Chapter 4 Global Inhalation & Nasal Spray Generic Drugs Market - Segment Analysis, By Drug Class, 2018 - 2030 (USD Million)

  • 4.1 Global Inhalation & Nasal Spray Generic Drugs Market: Drug Class Movement Analysis
  • 4.2 Bronchodilators
    • 4.2.1 Bronchodilators market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.3 Combination Drugs
    • 4.3.1 Combination drugs market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.4 Corticosteroids
    • 4.4.1 Corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.5 Decongestant Sprays
    • 4.5.1 Decongestant sprays market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.6 Antihistamines
    • 4.6.1 Antihistamines market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.7 Others
    • 4.7.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5 Global Inhalation & Nasal Spray Generic Drugs Market - Segment Analysis, by Indication, 2018 - 2030 (USD Million)

  • 5.1 Global Inhalation & Nasal Spray Generic Drugs Market: Indication Movement Analysis
  • 5.2 Asthma
    • 5.2.1 Asthma market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.3 Chronic Obstructive Pulmonary Disease (COPD)
    • 5.3.1 Chronic obstructive pulmonary disease market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.4 Allergic Rhinitis
    • 5.4.1 Allergic rhinitis market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.5 Others
  • 5.5. 1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6 Global Inhalation & Nasal Spray Generic Drugs Market - Segment Analysis, By Patient Demographics, 2018 - 2030 (USD Million)

  • 6.1 Global Inhalation & Nasal Spray Generic Drugs Market: Patient Demographics Movement Analysis
  • 6.2 Adult Patient
    • 6.2.1 Adult patient market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.3 Pediatric Patient
    • 6.3.1 Pediatric patient market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4 Geriatric Patient
    • 6.4.1 Geriatric patient market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7 Global Inhalation & Nasal Spray Generic Drugs Market - Segment Analysis, By End-User, 2018 - 2030 (USD Million)

  • 7.1 Global Inhalation & Nasal Spray Generic Drugs Market: End-user Movement Analysis
  • 7.2 Hospitals
    • 7.2.1 Hospital market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.3 Cancer Institutes
    • 7.3.1 Cancer Institutes market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4 Others
    • 7.4.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8 Global Inhalation & Nasal Spray Generic Drugs Market - Segment Analysis, By Distribution Channel, 2018 - 2030 (USD Million)

  • 8.1 Global Inhalation & Nasal Spray Generic Drugs Market: Distribution ChannelMovement Analysis
  • 8.2 Retail Pharmacies
    • 8.2.1 Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.3 Hospitals Pharmacies
    • 8.3.1 Hospitals pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.4 Online Pharmacies
    • 8.4.1 Online pharmacies market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Inhalation & Nasal Spray Generic Drugs Market: Segment Analysis, by Region, 2018 - 2030 (USD Million)

  • 9.1 Inhalation & Nasal Spray Generic Drugs Market: Regional Movement Analysis
    • 9.1.1 North America
      • 9.1.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.1.2 U.S.
      • 9.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.1.3 Canada
      • 9.1.1.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.1.2 Europe
      • 9.1.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.2.2 U.K.
      • 9.1.2.2.1 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.2.3 Germany
      • 9.1.2.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.2.4 France
      • 9.1.2.4.1 France market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.2.5 Spain
      • 9.1.2.5.1 Spain market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.2.6 Italy
      • 9.1.2.6.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.2.7 Russia
      • 9.1.2.7.1 Russia market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.1.3 Asia Pacific
      • 9.1.3.1 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.3.2 Japan
      • 9.1.3.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.3.3 China
      • 9.1.3.3.1 China market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.3.4 India
      • 9.1.3.4.1 India market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.3.5 Australia
      • 9.1.3.5.1 Australia market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.3.6 South Korea
      • 9.1.3.6.1 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.3.7 Singapore
      • 9.1.3.7.1 Singapore market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.1.4 Latin America
      • 9.1.4.1 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.4.2 Brazil
      • 9.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.4.3 Mexico
      • 9.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.4.4 Argentina
      • 9.1.4.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.1.5 Middle East & Africa
      • 9.1.5.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.5.2 South Africa
      • 9.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.5.3 Saudi Arabia
      • 9.1.5.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.5.4 United Arab Emirates
      • 9.1.5.4.1 United Arab Emirates market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 10 Global Inhalation & Nasal Spray Generic Drugs Market: Competitive Analysis

  • 10.1 Recent Developments and Impact Analysis, by Key Market Participants
    • 10.1.1 Major deals & strategic alliances analysis
      • 10.1.1.1 New Product Launches
      • 10.1.1.2 Mergers and Acquisitions
      • 10.1.1.3 Partnerships & Agreements
  • 10.2 Company Categorization
    • 10.2.1 Innovators
    • 10.2.2 Market Leaders
    • 10.2.3 Emerging Players
    • 10.2.4 Heat Map Analysis
  • 10.3 Company Market Position Analysis
  • 10.4 Vendor Landscape
    • 10.4.1 List of Key Distributors and Channel Partners
    • 10.4.2 List of Potential End Users
    • 10.4.3 Key Company Market Share Analysis, 2021
  • 10.5 Company Market Share, 2021
    • 10.5.1 Competitive Dashboard Analysis
  • 10.6 Private Companies
    • 10.6.1 List of Key Emerging Companies
    • 10.6.2 Regional Network Map
  • 10.7 Company Profiles
    • 10.7.1 Teva Pharmaceuticals
      • 10.7.1.1 Company overview
      • 10.7.1.2 Financial performance
      • 10.7.1.3 Product benchmarking
      • 10.7.1.4 Strategic initiatives
    • 10.7.2 Viatris Inc.
      • 10.7.2.1 Company overview
      • 10.7.2.2 Financial performance
      • 10.7.2.3 Product benchmarking
      • 10.7.2.4 Strategic initiatives
    • 10.7.3 Akorn, Inc.
      • 10.7.3.1 Company overview
      • 10.7.3.2 Financial performance
      • 10.7.3.3 Product benchmarking
      • 10.7.3.4 Strategic initiatives
    • 10.7.4 Cipla Inc.
      • 10.7.4.1 Company overview
      • 10.7.4.2 Financial performance
      • 10.7.4.3 Product benchmarking
      • 10.7.4.4 Strategic initiatives
    • 10.7.5 Sandoz (Novartis AG)
      • 10.7.5.1 Company overview
      • 10.7.5.2 Financial performance
      • 10.7.5.3 Product benchmarking
      • 10.7.5.4 Strategic initiatives
    • 10.7.6 Apotex Inc.
      • 10.7.6.1 Company overview
      • 10.7.6.2 Product benchmarking
      • 10.7.6.3 Strategic initiatives
    • 10.7.7 Hikma Pharmaceuticals PLC
      • 10.7.7.1 Company overview
      • 10.7.7.2 Financial performance
      • 10.7.7.3 Product benchmarking
    • 10.7.8 Sun Pharma
      • 10.7.10.1 Company overview
      • 10.7.10.2 Financial performance
      • 10.7.10.3 Product benchmarking
      • 10.7.10.4 Strategic initiatives
    • 10.7.9 Beximco Pharmaceuticals Limited
      • 10.7.9.1 Company overview
      • 10.7.9.2 Financial performance
      • 10.7.9.3 Product benchmarking
      • 10.7.9.4 Strategic initiatives
    • 10.7.10 Nephron Pharma
      • 10.7.10.1 Company overview
      • 10.7.10.2 Financial performance
      • 10.7.10.3 Product benchmarking
      • 10.7.10.4 Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Inhalation & Nasal Spray Generic Drugs Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 Global Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 5 Global Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 6 Global Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 7 Global Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 8 Global Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 9 North America Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 10 North America Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 11 North America Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 12 North America Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 13 North America Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 14 U.S. Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 15 U.S. Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 16 U.S. Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 17 U.S. Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 18 U.S. Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 19 Canada Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 20 Canada Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 21 Canada Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 22 Canada Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 23 Canada Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 24 Europe Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 25 Europe Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 26 Europe Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 27 Europe Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 28 Europe Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 29 Germany Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 30 Germany Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 31 Germany Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 32 Germany Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 33 Germany Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 34 U.K. Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 35 U.K. Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 36 U.K. Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 37 U.K. Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 38 U.K. Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 39 France Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 40 France Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 41 France Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 42 France Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 43 France Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 44 Italy Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 45 Italy Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 46 Italy Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 47 Italy Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 48 Italy Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 49 Spain Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 50 Spain Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 51 Spain Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 52 Spain Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 53 Spain Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 54 Russia Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 55 Russia Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 56 Russia Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 57 Russia Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 58 Russia Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 64 Japan Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 65 Japan Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 66 Japan Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 67 Japan Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 68 Japan Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 69 China Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 70 China Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 71 China Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 72 China Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 73 China Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 74 India Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 75 India Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 76 India Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 77 India Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 78 India Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 79 South Korea Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 80 South Korea Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 81 South Korea Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 82 South Korea Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 83 South Korea Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 84 Australia Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 85 Australia Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 86 Australia Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 87 Australia Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 88 Australia Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 89 Singapore Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 90 Singapore Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 91 Singapore Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 92 Singapore Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 93 Singapore Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 94 Latin America Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 95 Latin America Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 96 Latin America Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 97 Latin America Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 98 Latin America Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 99 Brazil Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 100 Brazil Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 101 Brazil Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 102 Brazil Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 103 Brazil Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 104 Mexico Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 105 Mexico Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 106 Mexico Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 107 Mexico Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 108 Mexico Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 109 Argentina Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 110 Argentina Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 111 Argentina Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 112 Argentina Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 113 Argentina Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 114 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 115 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 116 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 117 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 118 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 119 Saudi Arabia Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 120 Saudi Arabia Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 121 Saudi Arabia Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 122 Saudi Arabia Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 123 Saudi Arabia Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 124 South Africa Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 125 South Africa Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 126 South Africa Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 127 South Africa Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 128 South Africa Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 129 UAE Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 130 UAE Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 131 UAE Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 132 UAE Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 133 UAE Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Inhalation &nasal spray generic drugs market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Inhalation &nasal spray generic drugs market snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook, revenue, 2021 (USD Million)
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Inhalation &nasal spray generic drugs market driver impact
  • Fig. 14 Inhalation & nasal spray generic drugs market restraint impact
  • Fig. 15 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 16 Industry Analysis - Porter's
  • Fig. 17 Strategy mapping
  • Fig. 18 Inhalation &nasal spray generic drugs market: Drug class outlook and key takeaways
  • Fig. 19 Inhalation &nasal spray generic drugs market: Drug class movement analysis & market share 2021 & 2030
  • Fig. 20 Bronchodilators market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Combination market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Decongestant sprays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Antihistamines market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Inhalation &nasal spray generic drugs market: Indication outlook and key takeaways
  • Fig. 27 Inhalation &nasal spray generic drugs market: Indication movement analysis & market share 2021 & 2030
  • Fig. 28 Asthma market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Chronic Obstructive Pulmonary Disease (COPD) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Allergic rhinitis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Inhalation & nasal spray generic drugs market: Patient demographics outlook and key takeaways
  • Fig. 33 Inhalation & nasal spray generic drugs market: Patient demographics movement analysis & market share 2021 & 2030
  • Fig. 34 Adult patient market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Pediatric patient market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Geriatric patient market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Inhalation & nasal spray generic drugs market: End-user outlook and key takeaways
  • Fig. 38 Inhalation & nasal spray generic drugs market: End-user movement analysis & market share 2021 & 2030
  • Fig. 39 Homecare market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Inhalation & nasal spray generic drugs market: Distribution channel outlook and key takeaways
  • Fig. 43 Inhalation & nasal spray generic drugs market: Distribution channel movement analysis & market share 2021 & 2030
  • Fig. 44 Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Hospitals pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Online pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Inhalation & nasal spray generic drugs: Regional outlook and key takeaways
  • Fig. 48 Regional outlook, 2021 & 2030
  • Fig. 49 North America
  • Fig. 50 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 U.S.
  • Fig. 52 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Canada
  • Fig. 54 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Europe
  • Fig. 56 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 U.K.
  • Fig. 58 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Germany
  • Fig. 60 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 France
  • Fig. 62 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Italy
  • Fig. 64 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Spain
  • Fig. 66 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Russia
  • Fig. 68 Russia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Asia Pacific
  • Fig. 70 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Japan
  • Fig. 72 Japan market estimates and forecast, 2018 - 2030(USD Million)
  • Fig. 73 China
  • Fig. 74 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 India
  • Fig. 76 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 South Korea
  • Fig. 78 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 Australia
  • Fig. 80 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Singapore
  • Fig. 82 Singapore market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Latin America
  • Fig. 84 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Brazil
  • Fig. 86 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 Mexico
  • Fig. 88 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 Argentina
  • Fig. 90 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 91 Middle East & Africa
  • Fig. 92 MEA market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 93 South Africa
  • Fig. 94 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 95 Saudi Arabia
  • Fig. 96 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 97 UAE
  • Fig. 98 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 99 Market differentiators
  • Fig. 100 Key company market share analysis, 2021
  • Fig. 101 Company market position analysis
  • Fig. 102 Competitive dashboard analysis
  • Fig. 103 Regional network map